Public COA audit

NAD+ · NAD+ 500mg BUFFERED

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
88
Confidence
92%
Panels
4/7
Purity (printed)
99.91%

Scored high because the document is mostly consistent but carries soft concerns, limited panel coverage (4/7), and 1 soft concern. To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
NADB-072026-3
Identity method
LC-MS
Sample date
2026-06-24
Issue date
2026-06-26

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

4 of 7 present · 4 passed · 0 failed · 0 reported · 3 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    NAD+ confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.91%

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Tested · passed

    Bioburden / microbial limits testing.

    No Detectable Microbial DNA

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    Pass (both replicates), ≤0.05 EU/mL sensitivity

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    HPLC-UV purity of 99.91% with supporting chromatogram and mass spectrometry confirmation. This is normal for research-grade NAD+.

  • Identity confirmed by LC-MS

    Mass confirmation spectrum shows expected NAD+ molecular ion peaks (663.109 m/z for [NAD-H]-).

  • Lot number present

    Lot NADB-072026-3 clearly stated with accession number 2606240006 and search code.

  • Dates within normal range

    Received 2026-06-24, reported 2026-06-26 (2-day turnaround). Both dates are on or before today (2026-09-05).

  • Lab verification not independently confirmed

    Freedom Diagnostics Testing website and contact provided, but independent verification of lab accreditation/credentials not performed from this document alone.

  • Core panels present

    Identity (LC-MS), purity (HPLC-UV), endotoxin (LAL per USP <85>), and microbial (PCR) testing all performed and passed. Heavy metals, sterility, and residual solvents not included but this is common for many research peptide vendors.

  • Endotoxin testing comprehensive

    Two replicates tested using validated LAL assay with stated sensitivity (≤0.05 EU/mL), both passing. Method reference to USP <85> is appropriate.

  • Professional presentation

    Document includes lab logo, QR code for verification, chromatogram, mass spectrum, dual-vial testing with individual purity/content results, and appropriate research-use-only disclaimer.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.